Delivery Order SPE2DB22D6029-SPE2DB25FLUQH

Award Date 3/24/25
Potential Completion Date 4/14/25
Potential Value $8.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,896.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAFINLAR 75 MG CAPSULE 120S, a pharmaceutical product, and has an ultimate completion date of March 13, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TAFINLAR 75 MG CAPSULE 120S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,139.33 and an ultimate completion date of November 5, 2024. Amerisourcebergen, through its Corporate Office division, will supply this medication to support military treatment facilities and other federal healthcare providers....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,836.26 firm fixed-price delivery order is for the supply of TAFINLAR 50 MG CAPSULE 120S and has an ultimate completion date of April 16, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,836.26 delivery order contract is for the supply of TAFINLAR 50 MG CAPSULE 120S, a pharmaceutical product. The contract is a firm fixed price type with an ultimate completion date of February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $8,139.33 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 120 count capsules of the oncology medication TAFINLAR 75 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $35,081.48 and is for the delivery of TAFINLAR 75 MG CAPSULE 120S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of February 5, 2025. This award is associated...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,792.82 firm fixed-price delivery order is for the supply of TAFINLAR 75 MG CAPSULE 120S, a pharmaceutical product, with a period of performance through February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the drug TAFINLAR 75 MG CAPSULE 120S. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $8,896.41. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, with a ceiling value of $8,139.33, is for the delivery of TAFINLAR 75 MG CAPSULE 120S, a type of prescription pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 9, 2024. This award is part of a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of 120 counts of the pharmaceutical drug TAFINLAR 75 MG CAPSULE. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,896.41 and is a Firm Fixed Price Delivery Order with a period of performance through March 5, 2025. The contract is not designated as a set-aside....
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLUQH
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order (DO) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAFINLAR 75 MG CAPSULE 120S. The award has a firm fixed price of $8,896.42 and a completion date of April 14, 2025.

The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This DO is likely part of that broader IDC, enabling efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 6/29/25, 1:17 AM